We serve as a link between scientists and the society, by bridging the gap between CRG early stage research and the market
- ANABEL SANZ
- Head of TBDO
We translate new scientific knowledge into benefits for health and value for society
- LUIS SERRANO
- CRG Director
Our research has the potential to improve people’s lives
- MARA DIERSSEN
- Head of the “Cellular and Systems Neurobiology” Group
For CRG Community & Inventors
Research activities often lead to discoveries and inventions, and to the development of new tools and materials that may benefit society. TBDO helps CRG scientists realize the potential of their cutting-edge research, promoting the transition of their discoveries and ideas from the lab into real-life benefits.
Learn more
For Industry & Investors
CRG offers a variety of cutting-edge avenues for collaboration. TBDO is committed to working with industry partners and investors for the progression of CRG research into benefits for society. Our team facilitates this translation by fostering relationships that bridge the gap between early stage technologies and commercialization.
Learn more
For Entrepreneurs
CRG is a globally recognized leader in knowledge creation. TBDO nurtures this fertile environment by providing its community with the knowledge, support and networking opportunities needed to develop an entrepreneurial mindset to make social impact.
Learn moreThe Technology & Business Development Process at CRG
Learn more about the Technology Transfer Process at CRG through our FAQs
Latest news
CRG ENTREPRENEURSHIP WEEK
For the first time, we celebrate the Entrepreneurship Week at CRG, a time to meet and discuss with innovators and the entrepreneurship community who dream big and inspire others to bring their ideas to life driving socio-economic growth and welfare. Directed to students, researchers, alumni, mentors, start-ups, industry, investors and other innovation partners, please find below activities scheduled during next week:
April 27-30
CRG BioBusiness School
Registration closed (selected candidates)
April 27 12:00h-13:00h
"The Scientist's Journey"
...
a href=https://www.crg.eu/en/event/tbdo-sessions-edgardo-ferranTBDO Sessions Edgardo Ferran/a
pspan class=body_120/06/2019/spanspan class=body_216:00/spanspan class=body_3CHARLES DARWIN/spanspan class=body_4TBDO Sessions/spanspan class=body_5Edgardo Ferran/spanspan class=body_6EMBL_EBI visiting scientist/CRG scientific collaborator/spanspan class=body_7An introduction to Pharma Industry and EBI Industry Programme/spanspan class=body_8Host: Montava Guill, Ester/spanspan class=body_9Abstract:/spanWhy do we need pharma industry? What is the current business model of the big pharma? How drug discovery and development is done in these companies? How many new medicines are approved each year by the regulatory agencies? How the companies communicate their financial and clinical results? What a pharma clinical pipeline looks like? Which strategies do they follow under the risk of a patent cliff? Why pharma companies merge or buy a concurrent company? Which are the scientific subjects that currently interest the big pharma? How.../p
TBDO Sessions Edgardo Ferran
20/06/201916:00CHARLES DARWINTBDO SessionsEdgardo FerranEMBL_EBI visiting scientist/CRG scientific collaboratorAn introduction to Pharma Industry and EBI Industry ProgrammeHost: Montava Guill, EsterAbstract:Why do we need pharma industry? What is the current business model of the big pharma? How drug discovery and development is done in these companies? How many new medicines are approved each year by the regulatory agencies? How the companies communicate their financial and clinical results? What a pharma clinical pipeline looks like? Which strategies do they follow under the risk of a patent cliff? Why pharma companies merge or buy a concurrent company? Which are the scientific subjects that currently interest the big pharma? How...
